Innovotech Inc. (TSXV:IOT)

Market Cap	3.54M -67.9%
Revenue (ttm)	3.72M +2.6%
Net Income	-784.97K
EPS	-0.01
Shares Out	54.44M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Open	n/a
Previous Close	0.0650
Day's Range	n/a
52-Week Range	0.0650 - 0.2900
Beta	1.36
Analysts	n/a
Price Target	n/a
Est. Earnings	Nov 23, 2026

About Innovotech

Innovotech Inc. provides assay kits used in growing microbial biofilms for research purposes in Canada, the United States, and internationally. The company offers InnovoSIL, a silver periodate antimicrobial compounds for medical applications; and MBEC Assay kit, a screening assay used to determine the efficacy of antimicrobials against biofilms of a variety of microorganisms; pre-coated MBEC Assay lids; and order biofilm assays. It also provides antimicrobial contract research and antimicrobial testing; antimicrobial and anti-biofilm agents; an...

• Industry: Biotechnology
• Sector: Healthcare
• CEO: Craig Milne
• Employees: 16
• Stock Exchange: TSX Venture Exchange
• Ticker Symbol: IOT

Financial Performance

In 2025, Innovotech's revenue was 4.53 million, an increase of 106.65% compared to the previous year's 2.19 million. Earnings were 94,375, a decrease of -58.01%.

Data Sources: S&P Global Market Intelligence and QUODD

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by QUODD.

Last checked:

Oct 30, 2026

Data Sources Report a data error